| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Mara G. Aspinall last filed a Form 4 in May 2025, as Director at OSUR. The filings on record cover 3 companies. Mara G. Aspinall's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 44,139 shares of CSTL. The CSTL filings lean toward selling, a net 6,875 shares.
Mara G. Aspinall has 37 Form 4 filings on record from January 2015 to May 2025, across 4 companies: Director at Orasure Technologies (OSUR), 2017–2025; Director at Castle Biosciences (CSTL), 2019–2024; Director at Veradigm (MDRX), 2017–2021, and 1 more.
The 52 reported transactions were 19 option or other derivative awards, 14 stock awards, 7 tax withholdings and 4 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 4 purchases worth about $156K and 4 sales worth about $495K.
The largest open-market purchase was 5,000 shares of OSUR at an average $14.23 on November 7, 2017, about $71K.
The largest open-market sale was 2,500 shares of CSTL at an average $52.48 on October 2, 2020, about $131K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2022 | OSUR Orasure Technologies Inc | Director | Buy | 6,000 | $4.19 | $25,137.60 | +8.4% | +18.1% | +53.7% | |
| Oct 2, 2020 | CSTL Castle Biosciences Inc | Director | Sell | 2,500 | $52.48 | $131,200.00 | -7.5% | - | - | |
| Sep 9, 2020 | CSTL Castle Biosciences Inc | Director | Sell | 2,500 | $50.48 | $126,200.00 | -7.0% | - | - | |
| Sep 4, 2020 | CSTL Castle Biosciences Inc | Director | Sell | 2,500 | $48.48 | $121,200.00 | -6.5% | - | - | |
| Aug 28, 2020 | CSTL Castle Biosciences Inc | Director | Sell | 2,500 | $46.48 | $116,200.00 | -6.1% | - | - | |
| Jul 29, 2019 | CSTL Castle Biosciences Inc | Director | Buy | 3,125 | $16.00 | $50,000.00 | +8.3% | - | - | |
| Dec 14, 2018 | MDRX Veradigm Inc. | Director | Buy | 963 | $10.39 | $10,005.57 | +2.9% | - | - | |
| Nov 7, 2017 | OSUR Orasure Technologies Inc | Director | Buy | 5,000 | $14.23 | $71,163.50 | New | - | - |